We are live on ! Find out more
MBII

Marrone Bio Innovations, Inc.
MBII

Delisted

MBII was delisted on the 12th of July, 2022.

Back to rankings

24 hedge funds and large institutions have $17.5M invested in Marrone Bio Innovations, Inc. in 2017 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

4% more funds holding

Funds holding: 23 → 24 (+1)

10% less capital invested

Capital invested by funds: $19.5M → $17.5M (-$1.99M)

25% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 4

Holders
24
Holders Change
+1
Holders Change %
+4.35%
% of All Funds
0.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$26.4K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$23.8K
3
BlackRock
BlackRock
New York
+$14K
4
UBS Group
UBS Group
Switzerland
+$7.24K
5
AWS
AJ Wealth Strategies
New York
+$6.25K

Top Sellers

Rank Fund Capital Flow
1
Primecap Management
Primecap Management
California
-$261K
2
SIM
Spark Investment Management
New York
-$39K
3
WRF
Waddell & Reed Financial
Kansas
-$23.9K
4
RJFSA
Raymond James Financial Services Advisors
Florida
-$19.2K
5
FANJ
Financial Architects (New Jersey)
New Jersey
-$7K
Name Holding Trade Value Shares
Change 		Change in
Stake
WRF
1
Waddell & Reed Financial
Kansas
$9.19M -$23.9K -11,300 -0.2%
Primecap Management
2
Primecap Management
California
$5.3M -$261K -123,285 -4%
AAP
3
Ardsley Advisory Partners
Connecticut
$1.51M – – –
Vanguard Group
4
Vanguard Group
Pennsylvania
$665K +$1.69K +800 +0.2%
BCM
5
Bridgeway Capital Management
Texas
$353K – – –
Geode Capital Management
6
Geode Capital Management
Massachusetts
$145K – – –
SIM
7
Spark Investment Management
New York
$121K -$39K -18,393 -23%
Northern Trust
8
Northern Trust
Illinois
$48K +$5.22K +2,463 +11%
RJFSA
9
Raymond James Financial Services Advisors
Florida
$29K -$19.2K -9,061 -38%
AWS
10
AJ Wealth Strategies
New York
$29K +$6.25K +2,950 +25%
Citadel Advisors
11
Citadel Advisors
Florida
$24K +$26.4K +12,482 New
SC
12
Savant Capital
Illinois
$22K – – –
Susquehanna International Group
13
Susquehanna International Group
Pennsylvania
$22K +$23.8K +11,224 New
State Street
14
State Street
Massachusetts
$21K – – –
AF
15
Allworth Financial
California
$20K – – –
BlackRock
16
BlackRock
New York
$13K +$14K +6,611 New
GBBWRPM
17
Genovese Burford & Brothers Wealth & Retirement Plan Management
California
$7K – – –
UBS Group
18
UBS Group
Switzerland
$7K +$7.24K +3,416 New
LTFS
19
Ladenburg Thalmann Financial Services
Florida
$5K – – –
Creative Planning
20
Creative Planning
Kansas
$4K – – –
CG
21
Cutler Group
California
$2K – – –
Morgan Stanley
22
Morgan Stanley
New York
$1K – – –
FANJ
23
Financial Architects (New Jersey)
New Jersey
– -$7K -3,485 Closed
Bank of America
24
Bank of America
North Carolina
– -$3K -1,587 Closed

MBII Hedge Fund Activity: Q1 2017 in Review

24 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Marrone Bio Innovations, Inc. (MBII) for Q1 2017, worth a combined $17.5M — down 10% from $19.5M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new MBII positions and 2 closed out — a net gain of 2 holders — while 3 added to existing stakes and 4 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $26.4K. The largest seller was Primecap Management, cutting an estimated $261K.

  • 24 institutional investors held Marrone Bio Innovations, Inc. (MBII) as of Q1 2017, up from 23 in Q4 2016.
  • Funds reported $17.5M of Marrone Bio Innovations, Inc. stock for Q1 2017, down 10% quarter-over-quarter.
  • 4 funds opened new Marrone Bio Innovations, Inc. positions in Q1 2017 and 2 closed out, a net change of +2 holders.
  • The largest Marrone Bio Innovations, Inc. buyer in Q1 2017 was Citadel Advisors, an estimated $26.4K added.
  • The largest Marrone Bio Innovations, Inc. seller in Q1 2017 was Primecap Management, an estimated $261K sold.

Based on aggregated 13F filings for Q1 2017.